Skip to main content
SpringerLink
Log in

Distinct Radiochemotherapy Protocols Differentially Influence Cellular Proliferation and Expression of p53 and Bcl-2 in Glioblastoma Multiforme Relapses In Vivo

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Several protocols for the adjuvant treatment of glioblastoma multiforme (GBM) are currently being evaluated. In this context, little is known about the influence of radiochemotherapy on apoptosis and the expression of apoptosis-related proteins in vivo.

We have analyzed the incidence of apoptosis using in situ nick translation (ISNT) and expression of Ki-67 (MIB-1), p53 (DO-1 and DO-7), Bcl-2 and transglutaminase II (TGase II) by immunohistochemistry in 41 patients with GBM and their matched relapses. Sixteen patients received radiochemotherapy, 18 irradiation and 7 no treatment. Radiochemotherapy resulted in an increase in Bcl-2+ cells (p=0.013). Irradiation caused the reduction of MIB-1+ (p=0.0015), DO-7+ (p=0.0043) and the increase of Bcl-2+ cells (p=0.016). We calculated a positive correlation between high TGase II scores in patients preceding radiochemotherapy (p=0.0186) and no treatment (p=0.0158), low ISNT scores (p=0.0018) and high DO-1 scores (p=0.0233) in patients preceding irradiation and short time to progression.

These data show that distinct postsurgical radiochemotherapy protocols differentially alter cellular proliferation and expression of p53 and Bcl-2 in GBM relapses. Furthermore, we show that ISNT, DO-1 and TGase II labeling scores are therapy-specific predictors of time to progression in GBM patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Berkman RA, Clark WC, Saxena A, Robertson JT, Oldfield EH, Ali IU: Clonal composition of glioblastoma multiforme. J Neurosurg 77: 432-437, 1992

    Google Scholar 

  2. James CD, Carlbom E, Dumanski JP, Hansen M, Nordenskjold M, Collins VP, Cavenee WK: Clonal genomic alterations in glioma malignancy stages. Cancer Res 48: 5546-5551, 1988

    Google Scholar 

  3. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336, 1990

    Google Scholar 

  4. Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B: Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355: 846-847, 1992

    Google Scholar 

  5. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB: Wildtype p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89: 7491-7495, 1992

    Google Scholar 

  6. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD: Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70: 923-935, 1992

    Google Scholar 

  7. Fisher TC, Milner AE, Gregory CD, Jackman AL, Aherne GW, Hartley JA, Dive C, Hickman JA: Bcl-2 modulation of apoptosis is induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res 53: 3321-3326, 1993

    Google Scholar 

  8. Iwaki T, Miyazono M, Hitosumatsu T, Tateishi J: An immunohistochemical study of tissue transglutaminase in gliomas with reference to their cell dying processes. Am J Pathol 145: 776-778, 1994

    Google Scholar 

  9. Gold R, Schmied M, Rothe G, Zischler H, Breitschopf H, Wekerle H, Lassmann H: Detection of DNA fragmentation in apoptosis: application of in situ nick-translation to cell culture systems and tissue sections. J Histochem Cytochem 41: 1023-1030, 1993

    Google Scholar 

  10. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577-580, 1981

    Google Scholar 

  11. Lan HY, Mu W, Ng YY, Nikolic-Paterson DJ, Atkins RC: A simple, reliable, and sensitive method for nonradioactive in situ hybridization: use of microwave heating to improve hybridization efficiency and preserve tissue morphology. J Histochem Cytochem 44: 281-287, 1996

    Google Scholar 

  12. Deininger MH, Meyermann R: Multiple eptiope labeling by the exclusive use of alkaline phosphatase conjugates in immunohistochemistry. Histochem Cell Biol 110: 425-430, 1998

    Google Scholar 

  13. Figge C, Reifenberger G, Vogeley KT, Messing M, Roosen N, Wechsler W: Immunohistochemical demonstration of proliferating cell nuclear antigen in glioblastomas: pronounced heterogeneity and lack of prognostic significance. J Cancer Res Clin Oncol 118: 289-295, 1992

    Google Scholar 

  14. Wikstrand CJ, Grahmann FC, McComb RD, Bigner DD: Antigenic heterogeneity of human anaplastic gliomas and glioma-derived cell lines defined by monoclonal antibodies. J Neuropathol Exp Neurol 44: 229-241, 1985

    Google Scholar 

  15. Schiffer D, Cavalla P, Migheli A, Chio A, Giordana MT, Marino S, Attanasio A: Apoptosis and cell proliferation in human neuroepithelial tumors. Neurosci Lett 195: 81-84, 1995

    Google Scholar 

  16. Rainov NG, Dobberstein KU, Bahn H, Holzhausen HJ, Lautenschlager C, Heidecke V, Burkert W: Prognostic factors in malignant glioma: influence of the overexpression of oncogene and tumor-suppressor gene products on survival. J Neuro-Oncol 35: 13-28, 1997

    Google Scholar 

  17. Soini Y, Niemela A, Kamel D, Herva R, Bloigu R, Paakko P, Vahakangas K: p53 immunohistochemical positivity as a prognostic marker in intracranial tumours. APMIS 102: 786-792, 1994

    Google Scholar 

  18. Rieger L, Weller M, Bornemann A, Schabet M, Dichgans J, Meyermann R: Bcl-2 family protein expression in human malignant glioma: a clinical-pathological correlative study. J Neurol Sci 155: 68-75, 1998

    Google Scholar 

  19. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y, Fontana A: Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest 94: 954-964, 1994

    Google Scholar 

  20. Yin XM, Oltvai ZN, Korsmeyer SJ: BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369: 321-323, 1994

    Google Scholar 

  21. Trepel M, Groscurth P, Malipiero U, Gulbins E, Dichgans J, Weller M: Chemosensitivity of human malignant glioma: modulation by p53 gene transfer. J Neuro-Oncol 39: 19-32, 1998

    Google Scholar 

  22. Montenarh M: Biochemical properties of the growth suppressor/ oncoprotein p53. Oncogene 7: 1673-1680, 1992

    Google Scholar 

  23. Tada M, Matsumoto R, Iggo RD, Onimaru R, Shirato H, Sawamura Y, Shinohe Y: Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations. Cancer Res 58: 1793-1797, 1998

    Google Scholar 

  24. Haas-Kogan DA, Yount G, Haas M, Levi D, Kogan SS, Hu L, Vidair C, Deen DF, Dewey WC, Israel MA: p53-dependent G1 arrest and p53-independent apoptosis influence the radiobiologic response of glioblastoma. Int J Radiat Oncol Biol Phys 36: 95-103, 1996

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Brain Research, University of Tuebingen Medical School, Tuebingen, Germany

    Martin H. Deininger & Richard Meyermann

  2. Department of Neurosurgery, University of Tuebingen Medical School, Tuebingen, Germany

    Ernst Grote

  3. Department of Neurosurgery, Asklepios Kliniken Schildautal, Seesen, Germany

    Juergen Wickboldt

Authors
  1. Martin H. Deininger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ernst Grote
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Juergen Wickboldt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Richard Meyermann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Deininger, M.H., Grote, E., Wickboldt, J. et al. Distinct Radiochemotherapy Protocols Differentially Influence Cellular Proliferation and Expression of p53 and Bcl-2 in Glioblastoma Multiforme Relapses In Vivo. J Neurooncol 48, 121–129 (2000). https://doi.org/10.1023/A:1006462618800

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006462618800

Search

Navigation